Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BABAK BARMAR

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1972667202
CMS profile
361738
Location
LEESBURG, VA

General Payments · PY2018–2024

$1,125.49

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$522.49

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $505.60 16
Education $16.89 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $399.28 13
NOVARTIS PHARMACEUTICALS CORPORATION $67.56 1
CALLIDITAS THERAPEUTICS US INC. $23.87 1
Retrophin, Inc. $16.89 1
Ardelyx, Inc. $14.89 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $261.34 5
PY2019 $76.00 1
PY2021 $29.39 1
PY2022 $59.87 3
PY2023 $176.40 5
PY2024 $522.49 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $26.32 03/19/2024 Food and Beverage Undisputed 01/23/2026 1111524832 CMS
Amgen Inc. $28.95 04/15/2024 Food and Beverage Undisputed 01/23/2026 1111524834 CMS
Amgen Inc. $32.17 05/15/2024 Food and Beverage Undisputed 01/23/2026 1111524836 CMS
Amgen Inc. $2.27 05/28/2024 Food and Beverage Undisputed 01/23/2026 1111524856 CMS
Amgen Inc. $32.16 06/12/2024 Food and Beverage Undisputed 01/23/2026 1111524838 CMS
Amgen Inc. $29.52 09/04/2024 Food and Beverage Undisputed 01/23/2026 1111524840 CMS
Amgen Inc. $120.60 09/24/2024 Food and Beverage Undisputed 01/23/2026 1111524846 CMS
Amgen Inc. $28.85 10/08/2024 Food and Beverage Undisputed 01/23/2026 1111524842 CMS
Amgen Inc. $22.24 11/04/2024 Food and Beverage Undisputed 01/23/2026 1111524844 CMS
Amgen Inc. $19.56 11/04/2024 Food and Beverage Undisputed 01/23/2026 1111524848 CMS
Amgen Inc. $12.72 12/13/2024 Food and Beverage Undisputed 01/23/2026 1111524850 CMS
Amgen Inc. $23.22 12/16/2024 Food and Beverage Undisputed 01/23/2026 1111524852 CMS
Amgen Inc. $20.70 12/16/2024 Food and Beverage Undisputed 01/23/2026 1111524854 CMS
Ardelyx, Inc. $14.89 05/09/2024 Food and Beverage Undisputed 01/23/2026 1146670621 CMS
CALLIDITAS THERAPEUTICS US INC. $23.87 06/19/2024 Food and Beverage Undisputed 01/23/2026 1141517223 CMS
Novartis Pharmaceuticals Corporation $67.56 10/26/2024 Food and Beverage Undisputed 01/23/2026 1086778067 CMS
Travere Therapeutics, Inc. $16.89 04/11/2024 Education Undisputed 01/23/2026 1149930406 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.